About BioCentra Diagnostics
BioCentra Diagnostics is a company based in Houston (United States) founded in 2008.. BioCentra Diagnostics has raised $16.51 thousand across 1 funding round. BioCentra Diagnostics offers products and services including COVID-19 RT-PCR Test, Pharmacogenomics Psych Panel, TBioScan Dementia Risk Test, Respiratory Pathogen Panel, and UTI Pathogen Panel. BioCentra Diagnostics operates in a competitive market with competitors including Prenetics, TScan Therapeutics, Karius, Day Zero Diagnostics and Brii Biosciences, among others.
- Headquarter Houston, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$16.51 K (USD)
in 1 rounds
-
Latest Funding Round
$16.51 K (USD), Seed
Aug 11, 2015
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BioCentra Diagnostics
BioCentra Diagnostics offers a comprehensive portfolio of products and services, including COVID-19 RT-PCR Test, Pharmacogenomics Psych Panel, TBioScan Dementia Risk Test, Respiratory Pathogen Panel, and UTI Pathogen Panel. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Detects COVID-19 virus with same-day results for travel needs.
Assesses drug-gene interactions for personalized medication choices.
Evaluates genetic risk for dementia and Alzheimer’s disease.
Identifies viruses and bacteria in respiratory infections.
Detects bacteria and fungi in urinary tract infections.
Funding Insights of BioCentra Diagnostics
BioCentra Diagnostics has successfully raised a total of $16.51K through 1 strategic funding round. The most recent funding activity was a Seed round of $16.51 thousand completed in August 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $16,510
-
First Round
First Round
(11 Aug 2015)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2015 | Amount | Seed - BioCentra Diagnostics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by BioCentra Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioCentra Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biocentra Diagnostics Comparisons
Competitors of BioCentra Diagnostics
BioCentra Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, TScan Therapeutics, Karius, Day Zero Diagnostics and Brii Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
|
| domain | founded_year | HQ Location |
T cell-based treatments for immunological and oncological disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| domain | founded_year | HQ Location |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of biologics to treat hepatitis B infection
|
|
| domain | founded_year | HQ Location |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about BioCentra Diagnostics
When was BioCentra Diagnostics founded?
BioCentra Diagnostics was founded in 2008 and raised its 1st funding round 7 years after it was founded.
Where is BioCentra Diagnostics located?
BioCentra Diagnostics is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Is BioCentra Diagnostics a funded company?
BioCentra Diagnostics is a funded company, having raised a total of $16.51K across 1 funding round to date. The company's 1st funding round was a Seed of $16.51K, raised on Aug 11, 2015.
What does BioCentra Diagnostics do?
BioCentra Diagnostics was established in 2008 in Houston, Texas, within the medical diagnostics sector. A range of laboratory testing services is offered, encompassing mens and womens wellness panels, allergy assessments, infectious disease screenings, and urinary tract infection pathogen panels. These operations are centered in the United States, supporting clinical diagnostics for various health conditions.
Who are the top competitors of BioCentra Diagnostics?
BioCentra Diagnostics's top competitors include Prenetics, GigaGen and Shattuck Labs.
What products or services does BioCentra Diagnostics offer?
BioCentra Diagnostics offers COVID-19 RT-PCR Test, Pharmacogenomics Psych Panel, TBioScan Dementia Risk Test, Respiratory Pathogen Panel, and UTI Pathogen Panel.